ALKERMES PLC (ALKS:NASDAQ)
$52.89 -0.08 (-0.151%)
Analysed ALKERMES PLC (ALKS:NASDAQ) News Sources
Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation?
29-06-2026
yahoo.com
Sector Update: Healthcare Stocks Higher Late Afternoon
29-06-2026
yahoo.com
Alkermes (ALKS) Is Up 9.3% After Strong Alixorexton Phase 2 Data And Russell 2000 Addition - What's Changed
30-06-2026
yahoo.com
Arcturus Therapeutics (ARCT) Stock Jumps 5.7%: Will It Continue to Soar?
03-07-2026
yahoo.com
Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis
13-07-2026
yahoo.com
American Express, Biogen upgraded: Wall Street's top analyst calls
13-07-2026
yahoo.com
Alkermes to Report Second Quarter Financial Results on July 28, 2026
14-07-2026
yahoo.com
Axsome's NDA for AXS-12 in Narcolepsy Gets FDA Acceptance
16-07-2026
yahoo.com
Alkermes (ALKS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
21-07-2026
yahoo.com
Adaptive Biotechnologies (ADPT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
22-07-2026
yahoo.com
What is the current price of ALKERMES PLC (ALKS:NASDAQ)?
The current price of ALKERMES PLC (ALKS:NASDAQ) is $52.89.
ALKERMES PLC (ALKS:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALKERMES PLC (ALKS:NASDAQ) since the previous trading day is $-0.08.
ALKERMES PLC (ALKS:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALKERMES PLC (ALKS:NASDAQ) since the previous trading day is -0.151%.
What is the most recent average sentiment score for ALKERMES PLC (ALKS:NASDAQ)?
The most recent average sentiment score for ALKERMES PLC (ALKS:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for ALKERMES PLC (ALKS:NASDAQ)?
The most recent sentiment for ALKERMES PLC (ALKS:NASDAQ) is .
SEC-8K** Filing Available For ALKERMES PLC (ALKS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.